Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 626 participants.

Also called NCT06768138

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 626 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06768138
  • EU CT 2023-506935-14-01
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06768138. Randomized; single masking; primary purpose treatment. Start 2025-06-01 (actual); primary completion 2028-09-16 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke
Acronym
IA-SUCCESS
Condition
Stroke, Acute Ischemic
Intervention (Drug)
Intra-arterial infusion of Alteplase
Lead sponsor
Central Hospital, Nancy, France (class: other)

Record details

Record id
cardio:ct-nct06768138
Content hash
8689faae915d829d4d04cd42c889f0683497c409e8246fb1d78713bc7d0cd946